%0 Figure %A Sasaki, Ryu %A Yamasaki, Kazumi %A Abiru, Seigo %A Komori, Atsumasa %A Nagaoka, Shinya %A Saeki, Akira %A Hashimoto, Satoru %A Bekki, Shigemune %A Kugiyama, Yuki %A Kuno, Atsushi %A Korenaga, Masaaki %A Togayachi, Akira %A Ocho, Makoto %A Mizokami, Masashi %A Narimatsu, Hisashi %A Ichikawa, Tatsuki %A Nakao, Kazuhiko %A Yatsuhashi, Hiroshi %D 2015 %T Cumulative incidence of hepatocellular carcinoma (HCC) according to post-treatment WFA+-M2BP values, stratified by stage of fibrosis. %U https://plos.figshare.com/articles/figure/_Cumulative_incidence_of_hepatocellular_carcinoma_HCC_according_to_post_treatment_WFA_M2BP_values_stratified_by_stage_of_fibrosis_/1448163 %R 10.1371/journal.pone.0129053.g003 %2 https://plos.figshare.com/ndownloader/files/2109487 %K svr %K 238 patients %K wfa %K 12.04 cutoff index %K Sustained Virological Response Measurement %K hcc %K Chronic hepatitis C %K 2.0 COI %X

(A): F1/2 (n = 172). (B): F3/4 (n = 66). Cumulative incidences of HCC according to post-treatment WFA+-M2BP values were analyzed using the Kaplan-Meier method. The black solid and dotted lines indicate the stratified post-treatment WFA+-M2BP values with a COI ≤ 2.0 and a COI > 2.0, respectively. There were no significant differences in HCC incidence with F1/2 group (P = 0.09 by the log-rank test). On the other hand, the incidence rate differed significantly with F3/4 group (P < 0.01 by the log-rank test). The numbers of patients at risk at each time point are shown below the graphs.

%I PLOS ONE